Patient Information Leaflet system provides a useful alternative to traditional and bulky leaflets for small batch runs of drugs used for clinical trials
Inprint, a developer of the leaflet label, has announced the production of Inseal, a label leaflet that it says is Patient Information Leaflet (PIL) legislation friendly and offers child resistance.
These leaflet labels are described as an ideal way of attaching the necessary PIL to individual packets used in small batch runs for clinical trials or on vending machine dispensed-the-counter drugs while adding extra safety and security to the tablet packs.
The ability to attach PIL directly onto the tablet packets in the smaller leaflet label format reduces packaging and as a result reduces waste and creates a product that is cheaper to produce.
The legislation on medication and the distribution of medication has created thicker leaflets which can take up a lot of space in the carton but by using the small Inseal leaflet labels the same information is attached using less paper.
In some cases this eliminates the need for a carton all together.
The leaflet label is made of a thin paper attached to a sef-adhesive base, which provides added child resistance on the foil back of tablet packs by adding thickness and making the pack harder for children to break through.
Other companies have already opened the door for this type of child resistant packaging which is well received by government bodies, and Inseal says it meets these legal standards while living up to the standard set by other Inprint products.
The self-adhesive base label has a micro perforated or crosscut pattern that allows the pills to be pushed through for retrieval.
The Inseal blister pack meets the growing demand for leaflet labels that attach to individual and vending machine sized packages of tablet drugs.
